An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study)

BACKGROUND: Dalteparin sodium, a low-molecular-weight heparin, is indicated for prevention of clotting in the extracorporeal circuit during hemodialysis (HD). Product labeling recommends a fixed single-bolus dose of 5000 international units (IU) for HD sessions lasting up to 4 hours, but adjustable...

Descripción completa

Detalles Bibliográficos
Autores principales: Soroka, Steven, Agharazii, Mohsen, Donnelly, Sandra, Roy, Louise, Muirhead, Norman, Cournoyer, Serge, MacKinnon, Martin, Pannu, Neesh, Barrett, Brendan, Madore, François, Tennankore, Karthik, Wilson, Jo-Anne, Hilton, Fiona, Sherman, Nancy, Wolter, Kevin, Orazem, John, Feugère, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236648/
https://www.ncbi.nlm.nih.gov/pubmed/30542622
http://dx.doi.org/10.1177/2054358118809104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236648/
https://www.ncbi.nlm.nih.gov/pubmed/30542622
http://dx.doi.org/10.1177/2054358118809104

Ejemplares similares